Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Monthly Archives: March 2013

Studies: Pharma Promo Spending Down 8% in ‘12; Survey Finds Interest in Virtual Sales Calls

Norwalk, CT, March 20, 2013Pharmaceutical Commerce reports that Cegedim Strategic Data’s (CSD, Jersey City, NJ) annual summary of promotional spending showed a nearly across-the-board decline in 2012.  The year’s total spending of $27.35 billion dropping by 8% from 2011, which also had experienced a spending decline of 3 percent.

 CSD bases its data on a global panel of about 200,000 healthcare providers annually, getting responses on numbers of rep calls, quantities of samples handed over, meetings attended and so forth. Continue reading

Patient Groups Criticize Dem Calls for Medicare Price Negotiations

Washington, DC, March 20, 2013 — Sam Baker reports in The Hill that patient groups and conservative activists pushed back Tuesday against renewed calls for Medicare to negotiate the prices it pays for prescription drugs.  More than 330 patient groups, most of them state-based, wrote to lawmakers to oppose price negotiations in Medicare’s drug benefit. 

Price negotiations are a long-standing Democratic priority, and the policy is getting a new push as Congress looks for ways to trim entitlement spending, according to Baker. Continue reading

Bills to Overhaul Business Incentives on Hold for Now

Trenton, NJ, March 18, 2013 — Joshua Burd reports in NJBIZ that closely watched bills that would reshape the state’s business and development incentives will have to wait until at least early May, their two top sponsors said on Friday, as lawmakers fine-tune the measures while getting through several weeks of budget hearings.

However, the sponsors, Assemblyman Albert Coutinho (D-Newark) and Sen. Raymond Lesniak (D-Union), remain confident about the future of the legislation, with the effort garnering broad support and two related bills clearing their respective committees earlier this week. Continue reading

Virtua’s ‘How Healthcare Is Boosting Regional Economy’ Set for April 4

Vorhees, New Jersey, March 15, 2013Virtua will present a forum entitled “How Healthcare Is Boosting the Regional Economy and Beyond” on Thursday, April 4 from 8:00 to 10:30 a.m. at the Virtua Voohees Health and Wellness Center in Vorhees, NJ. 

The forum’s goal is to bring together thought leaders from healthcare, business, community and government to highlight the ways that healthcare and healthcare investments can foster economic develop and create jobs.  In addition, the forum’s goal is to identify potential ways that this event might foster future healthcare-related economic development in New Jersey. Continue reading

Lt. Governor Guadagno Announces Creation of Council on Innovation

Council Aims to Improve Collaborative Opportunities with Industry and Academia

Trenton, NJ, March 14, 2013 — Lt. Governor Kim Guadagno yesterday announced the formation of a new Council on Innovation to advise the State’s Partnership for Action on how industry and academia can better work together to improve New Jersey’s economy and attract more federal funding.

Creation of the Council is among 15 recommendations in a report released yesterday by New Jersey Policy Research Organization (NJPRO) and InnovationNJ.  

In addition, Lt. Governor Guadagno announced Secretary of Higher Education Rochelle Hendricks as the newest member of the New Jersey Partnership for Action. Continue reading

Innovation NJ and NJPRO’s ‘Building Bridges II’ Provides Recommendations for NJ ‘Innovation Ecosystem’

Lt. Governor Guadagno Announces Creation of ‘NJ Council on Innovation

Piscataway, NJ, March 13, 2013 — Academia, industry and government need to take action that will make it easier for New Jersey businesses and institutions of higher education to collaborate to discover and commercialize innovative new products, processes and services, according to a new report by the New Jersey Policy Research Organization (NJPRO) Foundation and Innovation NJ.

At a press conference held today at Rutgers University in Piscataway, NJPRO and Innovation NJ released their latest research publication, Building Bridges II:  Breaking Down Barriers — Perspectives from Academia and Industry on Building a New Jersey Innovation Ecosystem

The report is intended to serve as a catalyst to encourage academia, industry and the state to work together to meld their respective research and development (R&D) assets in ways that build out New Jersey’s “Innovation Ecosystem” and affirm the state’s historic role as a global leader in innovation. Continue reading

PhRMA Biologics Report: 900+ Biologic Medicines and Vaccines in Development

Washington, DC, March 12, 2013 — America’s biopharmaceutical companies are using biological processes to develop 907 medicines and vaccines targeting more than 100 diseases, according to a new report released yesterday by the Pharmaceutical Research and Manufacturers of America (PhRMA). Continue reading

TEDxNJIT to Host ‘Connections: Digital Everywhere’ April 4 at NJIT

Newark, NJ, March 11, 2013 — TEDxNJIT will host “Connections: Digital Everywhere” on April 4, 2013, at the Jim Wise Theater on the Campus of New Jersey Institute of Technology (NJIT) in Newark as well as via an accompanying live simulcast broadcast available to viewers worldwide.

The independently organized event, licensed by TED, will focus on connections and will feature leaders in the various fields discussing mechanisms for developing connections to expand the human experience and the role of technology in creating and enhancing connectivity.  Continue reading

Choose New Jersey Seeks Sponsors for NJ Pavilion at 2013 BIO International Conference

Princeton, NJ, March 7, 2013 — Choose New Jersey invites companies to co-sponsor and share the advantages that will come with being part of the New Jersey Pavilion at the 2013 BIO International Conference, which will be held April 22-25 at Chicago’s McCormick Place.

According to Choose New Jersey, by being a co-sponsor, not only will you secure visibility for your organization, your participation will help New Jersey to enhance its presence and extend its reach in the highly competitive life sciences industry, which, in turn, benefits the state economy, creating jobs and sales revenues. Continue reading

Forbes: Legendary Drug Industry Execs Warn U.S. Research Cuts Endanger Innovation, Economy

New York, NY, March 7, 2013 — Writing in Forbes, three legendary pharmaceutical industry executives write of the important role of government funding of research and development, innovation and science and the potential ramifications of the current federal budget sequestration.

The three authors of the Forbes opinion piece are Marc Tessier-Lavigne, President, The Rockefeller University and former Chief Scientific Officer, Genentech Inc.; P. Roy Vagelos, Chairman, Regeneron Pharmaceuticals, and Retired Chairman and CEO, Merck & Co.; and Elias Zerhouni, President R&D Sanofi and former Director of the National Institutes of Health.  Continue reading